KOBO Biotech

KOBO Biotech FCF per Share

The Free Cash Flow per Share of KOBO Biotech (531541.BO) as of Oct 23, 2026 is 0.09 INR. In the previous year, Free Cash Flow per Share was 0.37 INR — a change of -76.70% (lower).

FCF per Share

0.09INR

YoY

-76.70%

Last updated:

Free Cash Flow per Share of KOBO Biotech is 2024 0.09 INR. Free Cash Flow per Share of KOBO Biotech was 2023 0.37 INR. It decreases by -76.70% lower compared to the previous year.

The KOBO Biotech FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2017
13.63 INR
Jan 1, 2018
13.28 INR
Jan 1, 2019
8.80 INR
Jan 1, 2020
6.08 INR
Jan 1, 2021
5.74 INR
Jan 1, 2022
39.39 INR
Jan 1, 2023
0.37 INR
Jan 1, 2024
0.09 INR
The KOBO Biotech FCF per Share history
YEARFCF per ShareYoY
0.09INR-76.70%
0.37INR-99.07%
39.39INR+585.88%
5.74INR-5.59%
6.08INR-30.88%
8.80INR-33.71%
13.28INR-2.57%
13.63INR+474.73%
2.37INR-72.38%
8.59INR+861.19%
0.89INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KOBO Biotech Stock analysis

What does KOBO Biotech do? Kobo Biotech Ltd. focuses on manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The company operates within the pharmaceuticals sector, producing bulk drugs for the industry. Its primary market segment consists of pharmaceutical manufacturers seeking reliable API suppliers. The firm's Solapur site in India is currently inactive, with no operational activities ongoing there. The company's revenue streams derive from the sale of manufactured APIs and bulk drugs to pharmaceutical companies. These products are essential components in the production of finished pharmaceutical formulations. Kobo Biotech Ltd. serves as a key supplier within the pharmaceutical supply chain, providing critical raw materials to its clients. The business model centers on bulk drug manufacturing, with the company acting as a supplier to other pharmaceutical firms. There are no additional product lines or services mentioned beyond API and bulk drug production. The firm's focus remains strictly on the manufacturing of active pharmaceutical ingredients and bulk drugs for the pharmaceutical industry. KOBO Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KOBO Biotech stock

Free Cash Flow per Share of KOBO Biotech is 0.09 INR in 2024.

Free Cash Flow per Share of KOBO Biotech changed from 0.37 INR to 0.09 INR, representing a -76.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share KOBO Biotech since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — KOBO Biotech

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — KOBO Biotech